Introduction: Type 2 diabetes mellitus (T2DM) is no longer just a metabolic diagnosis; it is a daily test of confidence, endurance and quality of life. Traditional measures such as haemoglobin A1c (HbA1c) provide only a partial picture, while patients' beliefs about their ability to manage diabetes may be equally crucial. This scoping review examines how self‐efficacy and self‐care behaviours intersect with glycaemic control and health‐related quality of life (HRQoL) in adults with T2DM across diverse health systems and cultures. Methods: Following the Arksey and O'Malley framework and PRISMA‐ScR guidelines, a systematic search was conducted across four databases covering January 2016 to March 2026. Studies were eligible if they included adults aged ≥ 18 years with confirmed T2DM and examined at least one of the following: diabetes self‐efficacy, self‐care behaviours, glycaemic control (HbA1c) or HRQoL. Thirteen studies encompassing 5784 adults with T2DM were included, spanning cross‐sectional, longitudinal, quasi‐experimental and randomised controlled trial designs across seven countries. Results: Diabetes management self‐efficacy consistently outperformed knowledge in predicting self‐care behaviours and HbA1c, with patients holding stronger efficacy beliefs demonstrating better metabolic control and higher HRQoL. Interventions grounded in social cognitive theory and empowerment approaches achieved clinically meaningful HbA1c reductions alongside improvements in self‐care and quality of life. Advanced modelling identified a psychological cascade whereby health literacy enhanced empowerment and self‐efficacy, which in turn drove self‐care and improved glycaemic and HRQoL outcomes. Cluster analyses further revealed distinct high‐risk subgroups, underscoring the need for stratified, individualised interventions. Conclusion: In T2DM, self‐efficacy consistently emerged as a central psychological factor associated with self‐care behaviour, glycaemic control and quality of life. The available evidence suggests that theoretically grounded, individually tailored interventions addressing psychological and behavioural determinants, including self‐efficacy, self‐care, empowerment and resilience, hold promise for improving diabetes outcomes. However, further longitudinal and experimental research is needed to confirm these relationships.
Stigmatizing attitudes among nurses toward patients with substance use disorders (SUDs) and Opioid Use Disorder (OUD) represent a significant and pervasive
Aim: To map nursing interventions for pain and sleep disturbance among adults receiving immune checkpoint inhibitors and identify assessment and research gaps. Design: A scoping review. Review Methods: Eligible sources were charted using a standardized form and descriptively synthesized by intervention type, outcome, study design and evidence stream. Data Sources: PubMed, Scopus, ScienceDirect and the Cumulative Index to Nursing and Allied Health Literature were searched on 30 November 2025 for English‐language sources published from 1 January 2019 to 30 November 2025. Results: We included 10 sources: one randomized clinical trial, four systematic reviews, three of which included meta‐analysis, three observational studies, one mixed‐methods study and one structured clinical perspective/review. Four sources provided direct evidence from populations receiving immune checkpoint inhibitors, whereas six provided potentially transferable evidence from broader oncology populations. Electronic patient‐reported outcome monitoring produced promising findings in one immune checkpoint inhibitor trial. Broader oncology evidence identified potentially transferable pain‐management approaches. Two primary studies explicitly reported sleep‐related findings, but neither reported using a dedicated, validated sleep‐specific instrument. Sleep‐related content within broader symptom or quality‐of‐life assessments was distinguished from dedicated sleep assessment. No included ICI‐specific nursing intervention primarily targeted insomnia. Conclusion: Direct evidence for nurse‐led pain and sleep interventions during immune checkpoint inhibitor treatment remains limited. Findings from broader oncology populations should not be interpreted as evidence of effectiveness in this population. Implications for the Profession and/or Patient Care: Oncology nurses may consider assessing pain and sleep separately. Future research should incorporate validated sleep measures and explore interventions tailored to patients receiving immune checkpoint inhibitors. Impact: The study addressed the limited nursing evidence for managing pain and sleep disturbance during immune checkpoint inhibitor treatment. The main findings were the scarcity of direct intervention evidence and the absence of validated sleep‐specific assessment. The findings will inform oncology nurses, researchers and services caring for adults receiving immune checkpoint inhibitors. Reporting Method: The review followed the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses Extension for Scoping Reviews. Patient or Public Contribution: No patients or members of the public were involved in this review, which was based on published evidence.